Isolation of a new human retrovirus from West African patients with AIDS.
about
Origins of HIV and the AIDS pandemicA novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cellsThe human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infectionStructural features in TAR RNA of human and simian immunodeficiency viruses: a phylogenetic analysisPathogenesis of human immunodeficiency virus infectionHuman immunodeficiency virus type 1 (HIV-1) proviral DNA load in purified CD4+ cells by LightCycler real-time PCR.Crystal Structure of the HIV-2 Neutralizing Fab Fragment 7C8 with High Specificity to the V3 Region of gp125Alpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivoCyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitroReverse transcriptases from human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus (SIVMAC) are susceptible to inhibition by foscarnet and 3'-azido-3'-deoxythymidine triphosphateIn vitro anti-human immunodeficiency virus activities of Z- and E-methylenecyclopropane nucleoside analogues and their phosphoro-L-alaninate diestersA potent human immunodeficiency virus type 1 protease inhibitor, UIC-94003 (TMC-126), and selection of a novel (A28S) mutation in the protease active site.Adenallene and cytallene: acyclic-nucleoside analogues that inhibit replication and cytopathic effect of human immunodeficiency virus in vitroDideoxynucleosides are less inhibitory in vitro against human immunodeficiency virus type 2 (HIV-2) than against HIV-1Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replicationMultibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophagesDifferential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurineIn vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatineMechanism of anti-HIV action of masked alaninyl d4T-MP derivativesS-1153 inhibits replication of known drug-resistant strains of human immunodeficiency virus type 1Profile of the HIV epidemic in Cape Verde: molecular epidemiology and drug resistance mutations among HIV-1 and HIV-2 infected patients from distinct islands of the archipelagoRetroviruses and human disease.Persistent infection of macaques with simian-human immunodeficiency virusesOverview of HIV molecular epidemiology among people who inject drugs in Europe and Asia.HIV-1 Genetic Variability and Clinical ImplicationsFrequency of human immunodeficiency virus type-2 in hiv infected patients in Maputo City, MozambiqueVariability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in FranceNon-M variants of human immunodeficiency virus type 1.Bifunctional recombinant fusion proteins for rapid detection of antibodies to both HIV-1 and HIV-2 in whole bloodGoing wild: lessons from naturally occurring T-lymphotropic lentivirusesHuman colon epithelial cells productively infected with human immunodeficiency virus show impaired differentiation and altered secretion.Human immunodeficiency virus infection in childhood.[The assessment process within science and the nomination of Carlos Chagas for the Nobel prize for Physiology or Medicine].VPX mutants of HIV-2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytesIdentification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization.Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1.Lack of effect of cytoplasmic tail truncations on human immunodeficiency virus type 2 ROD env particle release activity.Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2)Monoclonal antibodies against human immunodeficiency virus (HIV) type 2 core proteins: cross-reactivity with HIV type 1 and simian immunodeficiency virus
P2860
Q22242661-8A2648B5-F18D-4CBF-9EE9-8DDAD988C143Q24300123-18CFC617-DFB7-499E-88F4-68E359854857Q24318267-18265DEA-543E-4F58-8075-5AFA385F3AF0Q24630462-AFC3043E-0094-4B8B-B0FC-AC5FB450F614Q24634681-1C2196A7-B4DB-47BB-97E8-01AAD8E2D8ABQ24811629-1E3F023B-658C-4AC8-97CE-805E78328A51Q27667679-073C5E10-590D-457C-86DE-4DE7F246E220Q28321244-A02BAF12-D2AE-4421-A918-F8BBB8A9161CQ28323877-B09BF320-A31F-4E29-9478-3F9F398F0BAEQ28334680-B8D74DF0-3129-47A9-851C-FAA02FD58982Q28339991-A6A3467E-6C5F-41EC-81E8-86D4FCF76256Q28343355-7428CD3B-6650-43CF-B40A-831DA4EEB783Q28344457-387EA917-6BB1-4A72-89FB-60D940997966Q28361285-E09ED89E-C30C-4339-BF09-6057D8BE1ADBQ28361679-948D0FAC-7E04-4896-8A45-0143157C13B3Q28368266-DDB65CA0-F829-436A-8F4C-76451D14EA63Q28369349-0EB99316-017D-40B2-A5C2-B26C1A8EF35DQ28378681-D2F19F3D-8C10-4455-8386-27AD5E1F27B3Q28378709-67346E80-9BB7-4A47-BA7E-FA9D006DACF6Q28378931-6CBF6E6F-FE81-4FE2-91AE-DCC402603089Q28379544-C002D615-4F52-43F8-AC15-DA6C89AD53F7Q28538242-BC0A7DA4-71EC-4D40-B52F-EF59165D54B1Q28769657-A7B47C34-662F-42E6-9DB6-A1AF80748832Q28775731-E4FE8128-5ECF-4722-A3CA-C1993805396EQ30249677-C85A8B2B-1604-4089-8D72-0CE114066B9EQ30352010-3099F603-FA79-4CE0-A8DB-D6478F7B4DD1Q30406079-FF0E4666-3875-4E08-905C-1B0F323117ABQ30417537-BAC5B46E-54B0-4D7D-AC9E-2408CF5AADAFQ30432689-5C677230-7029-495B-8969-8C28D0DF6DD1Q30825974-357FB6E6-2A6E-4406-B16D-0BA5698F6938Q31066870-7C1D91AD-5BA5-4CA4-A6FA-4599D1409801Q33271769-1071546D-B191-4194-B063-8C79BCBEFC21Q33413501-5055A439-DA03-4BAA-92A8-3A1DB56A00D1Q33418395-55A144E7-2419-4DD4-8D50-4BD786FFA5D9Q33563208-98B7A5E6-2E98-4613-B950-B726A8C02349Q33567984-03CA2683-C0BD-4884-A19F-3C788937C44CQ33639547-8E5CFE5A-9C06-4338-8A76-375044B43B43Q33639849-5941B0FB-8717-4A06-9F4C-674ACDC16065Q33640139-9FEFF65E-CE6D-4D74-9A94-77C81BE77170Q33649029-BF23A4E9-8684-4DEE-999A-893E0D1E7A67
P2860
Isolation of a new human retrovirus from West African patients with AIDS.
description
1986 nî lūn-bûn
@nan
1986 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Isolation of a new human retrovirus from West African patients with AIDS.
@ast
Isolation of a new human retrovirus from West African patients with AIDS.
@en
Isolation of a new human retrovirus from West African patients with AIDS.
@nl
type
label
Isolation of a new human retrovirus from West African patients with AIDS.
@ast
Isolation of a new human retrovirus from West African patients with AIDS.
@en
Isolation of a new human retrovirus from West African patients with AIDS.
@nl
prefLabel
Isolation of a new human retrovirus from West African patients with AIDS.
@ast
Isolation of a new human retrovirus from West African patients with AIDS.
@en
Isolation of a new human retrovirus from West African patients with AIDS.
@nl
P2093
P356
P1433
P1476
Isolation of a new human retrovirus from West African patients with AIDS.
@en
P2093
Brun-Vézinet F
Chamaret S
Laurent AG
Santos-Ferreira MO
P304
P356
10.1126/SCIENCE.2425430
P407
P577
1986-07-01T00:00:00Z